Healthcare Health/Fitness

Amgen Scraps Experimental Weight Loss Pill, Moves Forward With Injectable Drug in Development for Obesity

Amgen will discontinue its experimental weight loss pill and focus on developing injectable drugs and other obesity-related products.


USDA Recalls 16,000 Pounds of Walmart Ground Beef Over E. coli Contamination

The USDA announced a nationwide recall of over 16,000 pounds of ground beef sold at Walmart due to potential E. coli contamination. The beef originated from Cargill Meat Solutions in Hazleton, Pennsyl..

Peloton CEO Barry McCarthy to Step Down While the Company Faces a Series of Layoffs Due to Low Profits

Peloton undergoes leadership change with CEO Barry McCarthy stepping down, accompanied by layoffs of 15% of staff, following disappointing fiscal third-quarter results...

Novo Nordisk's Q1 Profit Surges 28%, Thanks To Booming Demand for Weight Loss Drugs

Novo Nordisk exceeded profit expectations in Q1 2024 with a 28% surge in net profit, driven by Wegovy's success...


Latest News

Chinese team arrives in Liberia to staff Ebola clinic
About 160 Chinese health workers arrived on Saturday in Liberia, where they are due to staff a new $41 million Ebola clinic that, unlike most other foreign interventions, is being built and fully run
Obamacare enters new phase over the weekend with little fanfare
President Barack Obama's plan to extend private health coverage to the uninsured entered a new uncertain phase on Saturday as U.S. government-backed online insurance marketplaces opened their 2015 pla
India's Aurobindo to buy U.S. nutritional supplements maker for $133 million
Indian generic drugmaker Aurobindo Pharma Ltd (ARBN.NS) said on Wednesday its U.S. unit won a bankruptcy auction to buy nutritional supplements maker Natrol Inc for $132.5 million.
U.S. releases low 2015 Obamacare enrollment forecast
The U.S. administration on Monday dramatically cut expectations for 2015 Obamacare enrollment, saying it aims to have a total of 9.1 million people enrolled in government-backed federal and state heal
Quest says content with diagnostics, does not need CRO
The chief executive of Quest Diagnostics Inc (DGX.N) said his company will stick to its core business of diagnostic testing and is not interested in acquiring a contract research organization (CRO), d
Thermo Fisher pledges to fix glitch in drug analysis software
Thermo Fisher Scientific has pledged to correct a glitch in software used to analyze data from clinical drug trials within "four to eight weeks", after independent experts highlighted a potential for
Pfizer beats sales and profit forecasts, mum on future deals
Pfizer Inc (PFE.N) reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs and demand for its medicines in emerging markets, but did not signal any acquisition p
Valeant ready to raise Allergan bid to at least $200/share
Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) on Monday said in a letter to Allergan Inc's (AGN.N) board of directors that it was prepared to raise its offer to at least $200 per share bu
Vernalis PLC Announces CTI Becomes Worldwide Licensee for Tosedostat
Vernalis plc today announces that CTI BioPharma Corp. (CTI), a US corporation publicly listed on NASDAQ, replaces the UK venture capital backed Chroma Therapeutics (Chroma) as worldwide licensee of to
Fujifilm says to buy U.S. vaccine maker as Ebola spreads
Japan's Fujifilm Holdings Corp said on Monday it would buy 49 percent of Texas-based Kalon Biotherapeutics LLC, which has expertise in manufacturing vaccines used against pandemic influenza, Ebola and
Real Time Analytics